Top

Journal of Gastrointestinal Surgery

Published in:

01-02-2014 | 2013 SSAT Poster Presentation

Postoperative Serum Amylase Predicts Pancreatic Fistula Formation Following Pancreaticoduodenectomy

Authors: Jordan M. Cloyd, Zachary J. Kastenberg, Brendan C. Visser, George A. Poultsides, Jeffrey A. Norton

Published in: Journal of Gastrointestinal Surgery | Issue 2/2014

Abstract

Introduction

Early identification of patients at risk for developing pancreatic fistula (PF) after pancreaticoduodenectomy (PD) may facilitate prevention or treatment strategies aimed at reducing its associated morbidity.

Materials and Methods

A retrospective review of 176 consecutive PD performed between 2006 and 2011 was conducted in order to analyze the association between the serum amylase on postoperative day 1 (POD1) and the development of PF.

Results

Serum amylase was recorded on POD1 in 146 of 176 PD cases (83.0 %). Twenty-seven patients (18.5 %) developed a postoperative PF: 6 type A, 19 type B, and 2 type C. Patients with a PF had a mean serum amylase on POD1 of 659 ± 581 compared to 246 ± 368 in those without a fistula (p < 0.001). On logistic regression, a serum amylase >140 U/L on POD1 was strongly associated with developing a PF (OR, 5.48; 95 % CI, 1.94–15.44). Sensitivity and specificity of a postoperative serum amylase >140 U/L was 81.5 and 55.5 %, respectively. Positive and negative predictive values were 29.3 and 93.0 %, respectively.

Conclusion

An elevated serum amylase on POD1 may be used, in addition to other prognostic factors, to help stratify risk for developing PF following PD.

S.-V. Shrikhande and M.-A. D’Souza, “Pancreatic fistula after pancreatectomy: evolving definitions, preventive strategies and modern management,” World J. Gastroenterol., vol. 14, no. 38, pp. 5789–5796, Oct. 2008.PubMedCrossRef

J. W. Lin, J. L. Cameron, C. J. Yeo, T. S. Riall, and K. D. Lillemoe, “Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula,” J. Gastrointest. Surg., vol. 8, no. 8, pp. 951–959, Dec. 2004.

S. A. Ahmad, M. J. Edwards, J. M. Sutton, S. S. Grewal, D. J. Hanseman, S. K. Maithel, S. H. Patel, D. J. Bentram, S. M. Weber, C. S. Cho, E. R. Winslow, C. R. Scoggins, R. C. Martin, H. J. Kim, J. J. Baker, N. B. Merchant, A. A. Parikh, and D. A. Kooby, “Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients,” Ann. Surg., vol. 256, no. 3, pp. 529–537, Sep. 2012.

Z. J. Kastenberg, J. M. Morton, B. C. Visser, J. A. Norton, and G. A. Poultsides, “Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?,” HPB (Oxford), vol. 15, no. 2, pp. 142–148, Feb. 2013.

B. Topal, G. Peeters, H. Vandeweyer, R. Aerts, and F. Penninckx, “Hospital cost-categories of pancreaticoduodenectomy,” Acta Chir. Belg., vol. 107, no. 4, pp. 373–377, Aug. 2007.PubMed

F. R. Spitz, J. L. Abbruzzese, J. E. Lee, P. W. Pisters, A. M. Lowy, C. J. Fenoglio, K. R. Cleary, N. A. Janjan, M. S. Goswitz, T. A. Rich, and D. B. Evans, “Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas,” J. Clin. Oncol., vol. 15, no. 3, pp. 928–937, Mar. 1997.PubMed

M. I. van Berge Henegouwen, L. T. De Wit, T. M. Van Gulik, H. Obertop, and D. J. Gouma, “Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant,” J. Am. Coll. Surg., vol. 185, no. 1, pp. 18–24, Jul. 1997.PubMedCrossRef

C. M. Vollmer Jr, N. Sanchez, S. Gondek, J. McAuliffe, T. S. Kent, J. D. Christein, and M. P. Callery, “A root-cause analysis of mortality following major pancreatectomy,” J. Gastrointest. Surg., vol. 16, no. 1, pp. 89–102; discussion 102–103, Jan. 2012.

J. M. Winter, J. L. Cameron, K. A. Campbell, D. C. Chang, T. S. Riall, R. D. Schulick, M. A. Choti, J. Coleman, M. B. Hodgin, P. K. Sauter, C. J. Sonnenday, C. L. Wolfgang, M. R. Marohn, and C. J. Yeo, “Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial,” J. Gastrointest. Surg., vol. 10, no. 9, pp. 1280–1290; discussion 1290, Nov. 2006.

10.

A. M. Lowy, J. E. Lee, P. W. Pisters, B. S. Davidson, C. J. Fenoglio, P. Stanford, R. Jinnah, and D. B. Evans, “Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease,” Ann. Surg., vol. 226, no. 5, pp. 632–641, Nov. 1997.PubMedCrossRef

11.

C. J. Yeo, J. L. Cameron, K. D. Lillemoe, P. K. Sauter, J. Coleman, T. A. Sohn, K. A. Campbell, and M. A. Choti, “Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial,” Ann. Surg., vol. 232, no. 3, pp. 419–429, Sep. 2000.PubMedCrossRef

12.

K. D. Lillemoe, J. L. Cameron, M. P. Kim, K. A. Campbell, P. K. Sauter, J. A. Coleman, and C. J. Yeo, “Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial,” J. Gastrointest. Surg., vol. 8, no. 7, pp. 766–772; discussion 772–774, Nov. 2004.

13.

A. N. Kingsnorth, “Duct to mucosa isolated Roux loop pancreaticojejunostomy as an improved anastomosis after resection of the pancreas,” Surg Gynecol Obstet, vol. 169, no. 5, pp. 451–453, Nov. 1989.PubMed

14.

C. J. Yeo, J. L. Cameron, M. M. Maher, P. K. Sauter, M. L. Zahurak, M. A. Talamini, K. D. Lillemoe, and H. A. Pitt, “A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy,” Ann. Surg., vol. 222, no. 4, pp. 580–588; discussion 588–592, Oct. 1995.

15.

C. Bassi, C. Dervenis, G. Butturini, A. Fingerhut, C. Yeo, J. Izbicki, J. Neoptolemos, M. Sarr, W. Traverso, and M. Buchler, “Postoperative pancreatic fistula: an international study group (ISGPF) definition,” Surgery, vol. 138, no. 1, pp. 8–13, Jul. 2005.PubMedCrossRef

16.

W. B. Pratt, M. P. Callery, and C. M. Vollmer Jr, “Risk prediction for development of pancreatic fistula using the ISGPF classification scheme,” World J Surg, vol. 32, no. 3, pp. 419–428, Mar. 2008.PubMedCrossRef

17.

M. P. Callery, W. B. Pratt, T. S. Kent, E. L. Chaikof, and C. M. Vollmer Jr, “A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy,” J. Am. Coll. Surg., vol. 216, no. 1, pp. 1–14, Jan. 2013.PubMedCrossRef

18.

R. T. P. Poon, S. T. Fan, C. M. Lo, K. K. Ng, W. K. Yuen, C. Yeung, and J. Wong, “External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial,” Ann. Surg., vol. 246, no. 3, pp. 425–433; discussion 433–435, Sep. 2007.

19.

S. M. M. de Castro, O. R. C. Busch, T. M. van Gulik, H. Obertop, and D. J. Gouma, “Incidence and management of pancreatic leakage after pancreatoduodenectomy,” Br J Surg, vol. 92, no. 9, pp. 1117–1123, Sep. 2005.PubMedCrossRef

20.

Y.-M. Yang, X.-D. Tian, Y. Zhuang, W.-M. Wang, Y.-L. Wan, and Y.-T. Huang, “Risk factors of pancreatic leakage after pancreaticoduodenectomy,” World J. Gastroenterol., vol. 11, no. 16, pp. 2456–2461, Apr. 2005.PubMed

21.

A. El Nakeeb, T. Salah, A. Sultan, M. El Hemaly, W. Askr, H. Ezzat, E. Hamdy, E. Atef, E. El Hanafy, A. El-Geidie, M. Abdel Wahab, and T. Abdallah, “Pancreatic Anastomotic Leakage after Pancreaticoduodenectomy. Risk factors, Clinical predictors, and Management (Single Center Experience),” World J Surg, Mar. 2013.

22.

M. L. DeOliveira, J. M. Winter, M. Schafer, S. C. Cunningham, J. L. Cameron, C. J. Yeo, and P.-A. Clavien, “Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy,” Ann. Surg., vol. 244, no. 6, pp. 931–937; discussion 937–939, Dec. 2006.

23.

S.-E. Lee, S.-H. Yang, J.-Y. Jang, and S.-W. Kim, “Pancreatic fistula after pancreaticoduodenectomy: a comparison between the two pancreaticojejunostomy methods for approximating the pancreatic parenchyma to the jejunal seromuscular layer: interrupted vs continuous stitches,” World J. Gastroenterol., vol. 13, no. 40, pp. 5351–5356, Oct. 2007.PubMed

24.

G. Veillette, I. Dominguez, C. Ferrone, S. P. Thayer, D. McGrath, A. L. Warshaw, and C. Fernández-del Castillo, “Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience,” Arch Surg, vol. 143, no. 5, pp. 476–481, May 2008.PubMedCentralPubMedCrossRef

25.

S. Satoi, S. Takai, Y. Matsui, N. Terakawa, R. Iwaki, J. Fukui, H. Yanagimoto, K. Takahashi, H. Toyokawa, H. Araki, A.-H. Kwon, and Y. Kamiyama, “Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancer,” Pancreas, vol. 33, no. 1, pp. 45–52, Jul. 2006.PubMedCrossRef

26.

K. K. Kazanjian, O. J. Hines, G. Eibl, and H. A. Reber, “Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients,” Arch Surg, vol. 140, no. 9, pp. 849–854; discussion 854–856, Sep. 2005.

27.

K. C. Conlon, D. Labow, D. Leung, A. Smith, W. Jarnagin, D. G. Coit, N. Merchant, and M. F. Brennan, “Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection,” Ann. Surg., vol. 234, no. 4, pp. 487–493; discussion 493–494, Oct. 2001.

28.

W. E. Fisher, S. E. Hodges, E. J. Silberfein, A. Artinyan, C. H. Ahern, E. Jo, and F. C. Brunicardi, “Pancreatic resection without routine intraperitoneal drainage,” HPB (Oxford), vol. 13, no. 7, pp. 503–510, Jul. 2011.

29.

V. V. Mehta, S. B. Fisher, S. K. Maithel, J. M. Sarmiento, C. A. Staley, and D. A. Kooby, “Is it time to abandon routine operative drain use? A single institution assessment of 709 consecutive pancreaticoduodenectomies,” J. Am. Coll. Surg., vol. 216, no. 4, pp. 635–642, Apr. 2013.PubMedCrossRef

30.

Q. Cheng, B. Zhang, Y. Zhang, X. Jiang, B. Zhang, B. Yi, X. Luo, and M. Wu, “Predictive factors for complications after pancreaticoduodenectomy,” J. Surg. Res., vol. 139, no. 1, pp. 22–29, May 2007.PubMedCrossRef

31.

N. Pecorelli, G. Balzano, G. Capretti, A. Zerbi, V. Di Carlo, and M. Braga, “Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital,” J. Gastrointest. Surg., vol. 16, no. 3, pp. 518–523, Mar. 2012.PubMedCrossRef

32.

C. M. Schmidt, O. Turrini, P. Parikh, M. G. House, N. J. Zyromski, A. Nakeeb, T. J. Howard, H. A. Pitt, and K. D. Lillemoe, “Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience,” Arch Surg, vol. 145, no. 7, pp. 634–640, Jul. 2010.PubMedCrossRef

33.

R. T. P. Poon and S. T. Fan, “Decreasing the pancreatic leak rate after pancreaticoduodenectomy,” Adv Surg, vol. 42, pp. 33–48, 2008.PubMedCrossRef

34.

G. Ramacciato, P. Mercantini, N. Petrucciani, G. R. Nigri, A. Kazemi, M. Muroni, M. Del Gaudio, A. Balesh, M. Cescon, A. Cucchetti, and M. Ravaioli, “Risk factors of pancreatic fistula after pancreaticoduodenectomy: a collective review,” Am Surg, vol. 77, no. 3, pp. 257–269, Mar. 2011.PubMed

35.

E. Molinari, C. Bassi, R. Salvia, G. Butturini, S. Crippa, G. Talamini, M. Falconi, and P. Pederzoli, “Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients,” Ann. Surg., vol. 246, no. 2, pp. 281–287, Aug. 2007.PubMedCrossRef

36.

R. P. Sutcliffe, N. Battula, A. Haque, A. Ali, P. Srinivasan, S. W. Atkinson, M. Rela, N. D. Heaton, and A. A. Prachalias, “Utility of drain fluid amylase measurement on the first postoperative day after pancreaticoduodenectomy,” World J Surg, vol. 36, no. 4, pp. 879–883, Apr. 2012.PubMedCrossRef

37.

M. Yamaguchi, H. Nakano, T. Midorikawa, Y. Yoshizawa, Y. Sanada, and K. Kumada, “Prediction of pancreatic fistula by amylase levels of drainage fluid on the first day after pancreatectomy,” Hepatogastroenterology, vol. 50, no. 52, pp. 1155–1158, Aug. 2003.PubMed

38.

J. M. Winter, J. L. Cameron, C. J. Yeo, B. Alao, K. D. Lillemoe, K. A. Campbell, and R. D. Schulick, “Biochemical markers predict morbidity and mortality after pancreaticoduodenectomy,” J. Am. Coll. Surg., vol. 204, no. 5, pp. 1029–1036; discussion 1037–1038, May 2007.

39.

T. Okabayashi, M. Kobayashi, I. Nishimori, T. Sugimoto, S. Onishi, and K. Hanazaki, “Risk factors, predictors and prevention of pancreatic fistula formation after pancreatoduodenectomy,” J Hepatobiliary Pancreat Surg, vol. 14, no. 6, pp. 557–563, 2007.PubMedCrossRef

40.

A. Gulbinas, G. Barauskas, and J. Pundzius, “Preoperative stratification of pancreas-related morbidity after the Whipple procedure,” Int Surg, vol. 89, no. 1, pp. 39–45, Mar. 2004.PubMed

41.

B. K. P. Goh, Y.-M. Tan, Y.-F. A. Chung, P.-C. Cheow, H.-S. Ong, W.-H. Chan, P. K. H. Chow, K.-C. Soo, W.-K. Wong, and L. L. P. J. Ooi, “Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution,” Arch Surg, vol. 143, no. 10, pp. 956–965, Oct. 2008.PubMedCrossRef

42.

K. S. Gurusamy, R. Koti, G. Fusai, and B. R. Davidson, “Somatostatin analogues for pancreatic surgery,” Cochrane Database Syst Rev, vol. 6, p. CD008370, 2012.

43.

T. Vanounou, W. B. Pratt, M. P. Callery, and C. M. Vollmer Jr, “Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands,” J. Am. Coll. Surg., vol. 205, no. 4, pp. 546–557, Oct. 2007.PubMedCrossRef

44.

J. Li-Ling and M. Irving, “Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials,” Br J Surg, vol. 88, no. 2, pp. 190–199, Feb. 2001.PubMedCrossRef

45.

C. Bassi, E. Molinari, G. Malleo, S. Crippa, G. Butturini, R. Salvia, G. Talamini, and P. Pederzoli, “Early versus late drain removal after standard pancreatic resections: results of a prospective randomized trial,” Ann. Surg., vol. 252, no. 2, pp. 207–214, Aug. 2010.PubMedCrossRef

Title: Postoperative Serum Amylase Predicts Pancreatic Fistula Formation Following Pancreaticoduodenectomy
Authors: Jordan M. Cloyd
Zachary J. Kastenberg
Brendan C. Visser
George A. Poultsides
Jeffrey A. Norton
Publication date: 01-02-2014
Publisher: Springer US
Published in: Journal of Gastrointestinal Surgery / Issue 2/2014
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-013-2293-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Postoperative Serum Amylase Predicts Pancreatic Fistula Formation Following Pancreaticoduodenectomy

Abstract

Introduction

Materials and Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Materials and Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2014

Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

Single-Incision Versus Conventional Laparoscopic Appendectomy: A Meta-analysis of Randomized Controlled Trials

Overexpressing TNF-Alpha in Pancreatic Ductal Adenocarcinoma Cells and Fibroblasts Modifies Cell Survival and Reduces Fatty Acid Synthesis via Downregulation of Sterol Regulatory Element Binding Protein-1 and Activation of Acetyl CoA Carboxylase

Trends in Treatment and Survival in Older Patients Presenting with Stage IV Colorectal Cancer

Endoscopic Ultrasound Staging of Stenotic Esophageal Cancers May Be Unnecessary to Determine the Need for Neoadjuvant Therapy

Laparoscopic Splenectomy: Perioperative Management, Surgical Technique, and Results